Cargando…

Real world long-term impact of intensive treatment on disease activity, disability and health-related quality of life in rheumatoid arthritis

BACKGROUND: The emphasis on treating rheumatoid arthritis (RA) intensively reduces disease activity but its impact in routine care is uncertain. We evaluated temporal changes in disease activities and outcomes in a 10-year prospective observational cohort study of patients in routine care at one uni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gullick, Nicola J., Ibrahim, Fowzia, Scott, Ian C., Vincent, Alexandra, Cope, Andrew P., Garrood, Toby, Panayi, Gabriel S., Scott, David L., Kirkham, Bruce W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390620/ https://www.ncbi.nlm.nih.gov/pubmed/30886994 http://dx.doi.org/10.1186/s41927-019-0054-y

Ejemplares similares

Rheumatoid arthritis patients with fibromyalgic clinical features have significantly less synovitis as defined by power Doppler ultrasound
por: Mian, Aneela N., et al.
Publicado: (2016)

Intensive therapy and remissions in rheumatoid arthritis: a systematic review
por: Hughes, Catherine D., et al.
Publicado: (2018)

Interleukin-17+CD8+ T Cells Are Enriched in the Joints of Patients With Psoriatic Arthritis and Correlate With Disease Activity and Joint Damage Progression
por: Menon, Bina, et al.
Publicado: (2014)

Defining the relationship between pain intensity and disease activity in patients with rheumatoid arthritis: a secondary analysis of six studies
por: Ibrahim, Fowzia, et al.
Publicado: (2022)

Characterization of missing data patterns and mechanisms in longitudinal composite outcome trial in rheumatoid arthritis
por: Ibrahim, Fowzia, et al.
Publicado: (2022)

A systematic review of guidelines for managing rheumatoid arthritis
por: Mian, Aneela, et al.
Publicado: (2019)

A systematic review of randomised controlled trials in rheumatoid arthritis: the reporting and handling of missing data in composite outcomes
por: Ibrahim, Fowzia, et al.
Publicado: (2016)

Psychometric properties of a new treatment expectation scale in rheumatoid arthritis: an application of item response theory
por: Ibrahim, Fowzia, et al.
Publicado: (2015)

Factors associated with disability in patients with rheumatoid arthritis with persistent moderate disease activity: a retrospective cohort study
por: Scott, Ian C., et al.
Publicado: (2020)

Current perspectives on tocilizumab for the treatment of rheumatoid arthritis: a review
por: Al-Shakarchi, Israa, et al.
Publicado: (2013)

Linking Power Doppler Ultrasound to the Presence of Th17 Cells in the Rheumatoid Arthritis Joint
por: Gullick, Nicola J., et al.
Publicado: (2010)

Heterogeneity of treatment responses in rheumatoid arthritis using group based trajectory models: secondary analysis of clinical trial data
por: Ibrahim, Fowzia, et al.
Publicado: (2023)

Optimal responses in disease activity scores to treatment in rheumatoid arthritis: Is a DAS28 reduction of >1.2 sufficient?
por: Mian, Aneela N., et al.
Publicado: (2016)

Mental health, fatigue and function are associated with increased risk of disease flare following TNF inhibitor tapering in patients with rheumatoid arthritis: an exploratory analysis of data from the Optimizing TNF Tapering in RA (OPTTIRA) trial
por: Bechman, Katie, et al.
Publicado: (2018)

The clinical effectiveness of intensive management in moderate established rheumatoid arthritis: The titrate trial
por: Scott, David, et al.
Publicado: (2020)

Infliximab improves vascular stiffness in patients with rheumatoid arthritis
por: Wong, M, et al.
Publicado: (2008)

Baseline predictors of remission, pain and fatigue in rheumatoid arthritis: the TITRATE trial
por: Lee, Sook Yan, et al.
Publicado: (2021)

Optimizing treatment with tumour necrosis factor inhibitors in rheumatoid arthritis—a proof of principle and exploratory trial: is dose tapering practical in good responders?
por: Ibrahim, Fowzia, et al.
Publicado: (2017)

Does intensive management improve remission rates in patients with intermediate rheumatoid arthritis? (the TITRATE trial): study protocol for a randomised controlled trial
por: Martin, Naomi H., et al.
Publicado: (2017)

Goal-directed therapy for RA in routine practice is associated with improved function in patients with disease duration up to 15 years
por: Gullick, Nicola J., et al.
Publicado: (2012)

T cells in rheumatoid arthritis
por: Cope, Andrew P
Publicado: (2008)

Changing clinical patterns in rheumatoid arthritis management over two decades: sequential observational studies
por: Mian, Aneela N, et al.
Publicado: (2016)

Anti-BIP antibodies in rheumatoid arthritis
por: Panayi, GS, et al.
Publicado: (2003)

Determinants of Disability in Rheumatoid Arthritis: A Community-Based Cohort Study
por: Krause, Megan L., et al.
Publicado: (2015)

Tofacitinib: Real-World Data and Treatment Persistence in Rheumatoid Arthritis
por: Bertoldi, Ilaria, et al.
Publicado: (2021)

Real-world retention rates of biologics in patients with rheumatoid arthritis
por: Takami, Kenji, et al.
Publicado: (2023)

Impact of intensive treatment and remission on health-related quality of life in early and established rheumatoid arthritis
por: Scott, I C, et al.
Publicado: (2016)

Real-world effectiveness and safety of tofacitinib and abatacept in patients with rheumatoid arthritis
por: Hirose, Wataru, et al.
Publicado: (2022)

A large two-centre study in to rates of influenza and pneumococcal vaccination and infection burden in rheumatoid arthritis in the UK
por: Subesinghe, Sujith, et al.
Publicado: (2016)

Disease activity trajectories for early and established rheumatoid arthritis: Real-world data from a rheumatoid arthritis cohort
por: Movahedi, Mohammad, et al.
Publicado: (2022)

Real-world evidence for secukinumab in UK patients with psoriatic arthritis or radiographic axial spondyloarthritis: interim 2-year analysis from SERENA
por: Gaffney, Karl, et al.
Publicado: (2023)

Binding immunoglobulin protein resolves rheumatoid synovitis: a xenogeneic study using rheumatoid arthritis synovial membrane transplants in SCID mice
por: Yoshida, Kaoru, et al.
Publicado: (2011)

Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial
por: Scott, David L, et al.
Publicado: (2015)

The impact of rheumatoid foot on disability in Colombian patients with rheumatoid arthritis
por: Rojas-Villarraga, Adriana, et al.
Publicado: (2009)

Similar risk of cardiovascular events in idiopathic inflammatory myopathy and rheumatoid arthritis in the first 5 years after diagnosis
por: Párraga Prieto, Cristina, et al.
Publicado: (2020)

Real world, big data cost of pharmaceutical treatment for rheumatoid arthritis in Greece
por: Souliotis, Kyriakos, et al.
Publicado: (2019)

Real-world comparative effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritis
por: Iwamoto, Naoki, et al.
Publicado: (2021)

Real-world treatment patterns for repository corticotropin injection in patients with rheumatoid arthritis
por: Busch, Howard, et al.
Publicado: (2022)

Systematic Literature Review of Real-World Evidence on Baricitinib for the Treatment of Rheumatoid Arthritis
por: Hernández-Cruz, Blanca, et al.
Publicado: (2023)

The determination and measurement of functional disability in rheumatoid arthritis
por: Wolfe, Frederick
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_hj4v6r2lkhb7sla7kim6mr3m8k